Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxShares Outstanding (Weighted Average)
Others
Ratios

Genprex (GNPX) Shares Outstanding (Weighted Average) (2016 - 2025)

Genprex (GNPX) has 10 years of Shares Outstanding (Weighted Average) data on record, last reported at $760502.0 in Q3 2025.

  • For Q3 2025, Shares Outstanding (Weighted Average) rose 1463.18% year-over-year to $760502.0; the TTM value through Sep 2025 reached $760502.0, up 1463.18%, while the annual FY2024 figure was $4.0 million, 192.89% up from the prior year.
  • Shares Outstanding (Weighted Average) reached $760502.0 in Q3 2025 per GNPX's latest filing, down from $21.5 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $47.9 million in Q3 2022 and bottomed at $48651.0 in Q3 2024.
  • Average Shares Outstanding (Weighted Average) over 5 years is $20.1 million, with a median of $4.0 million recorded in 2024.
  • Peak YoY movement for Shares Outstanding (Weighted Average): crashed 97.45% in 2022, then surged 1463.18% in 2025.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $47.1 million in 2021, then plummeted by 97.45% to $1.2 million in 2022, then increased by 14.09% to $1.4 million in 2023, then surged by 192.89% to $4.0 million in 2024, then tumbled by 81.02% to $760502.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding (Weighted Average) were $760502.0 in Q3 2025, $21.5 million in Q2 2025, and $15.3 million in Q1 2025.